Molecular neural crest cell markers enable discrimination of organophosphates in the murine cardiac embryonic stem cell test

• Published in: Toxicology reports 2021-01, Vol.8, p.1513-1520
• Main Authors: Mennen, R.H., Hallmark, N., Pallardy, M., Bars, R., Tinwell, H., Piersma, A.H.
• Format: Article
• Language: English
• Subjects: Cardiac embryonic stem cell test; Developmental toxicology; Neural crest; Organophosphates; Regular
• ISSN: 2214-7500; 2214-7500
• DOI: 10.1016/j.toxrep.2021.07.017

[Display omitted] •Organophosphates induced distinctive effects on neural crest cells within the ESTc.•Neural crest gene transcripts were of added value to the original ESTc read-out.•Mechanistic information adds value to the applicability of the ESTc. The cardiac embryonic stem cell test (ESTc) originally used the differentiation of beating cardiomyocytes for embryotoxicity screenings of compounds. However, the ESTc consists of a heterogeneous cell population, including neural crest (NC) cells, which are important contributors to heart development in vivo. Molecular markers for NC cells were investigated to explore if this approach improved discrimination between structurally related chemicals, using the three organophosphates (OP): chlorpyrifos (CPF), malathion (MLT), and triphenyl phosphate (TPP). To decrease the test duration and to improve the objective quantification of the assay read-out, gene transcript biomarkers were measured on study day 4 instead of the traditional cardiomyocyte beating assessment at day 10. Gene expression profiling and immunocytochemistry were performed using markers for pluripotency, proliferation and cardiomyocyte and NC differentiation. Cell proliferation was also assessed by measurements of embryoid body (EB) size and total protein quantification (day 7). Exposure to the OPs resulted in similar patterns of inhibition of beating cardiomyocyte differentiation and of myosin protein expression on day 10. However, these three chemically related compounds induced distinctive effects on NC cell differentiation, indicated by changes in expression levels of the NC precursor (Msx2), NC marker (Ap2α), and epithelial to mesenchymal transition (EMT; Snai2) gene transcripts. This study shows that investigating NC markers can provide added value for ESTc outcome profiling and may enhance the applicability of this assay for the screening of structurally related test chemicals.